A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

For example, without a subscription, the Medtronic Guardian Connect system costs around $5,000 CAN ($3,700 USD) per year, in large part thanks to the need to buy disposable sensors. So you can see ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

The GS implicated were Dexcom G6 (5% of its users), G5 (7.4%), Medtronic Enlite Sensor(15%), Medtronic Guardian Sensor 3(8.8%),and Freestyle libre (3.7%). Only 5 teams had reported the reaction to ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

The MiniMed™ 780G system is Medtronic’s most advanced insulin delivery system, automatically adjusting and correcting† glucose levels every 5 minutes.§ It’s the world’s only system with a Meal ...

Shares of Medtronic PLC climbed toward a three-month high in early Tuesday trading, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its ...

DUBLIN - Medtronic plc (NYSE:MDT), a global healthcare technology ... The system is currently compatible with the Guardian™ 4 sensor. Designed to ease the burden of carbohydrate counting and insulin ...